MANTLE CELL LYMPHOMA (MCL)
Clinical trials for MANTLE CELL LYMPHOMA (MCL) explained in plain language.
Never miss a new study
Get alerted when new MANTLE CELL LYMPHOMA (MCL) trials appear
Sign up with your email to follow new studies for MANTLE CELL LYMPHOMA (MCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat lymphoma when standard drugs fail
Disease control Not yet recruitingThis study is testing a new combination of four targeted drugs for adults with mantle cell lymphoma, a type of blood cancer, that has come back or stopped responding to a common type of medication called a BTK inhibitor. The goal is to see if this new drug mix can better control …
Matched conditions: MANTLE CELL LYMPHOMA (MCL)
Phase: PHASE4 • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Pioneering cancer treatment trial launches in colombia
Disease control Not yet recruitingThis study has two main goals. First, it aims to set up the systems needed to make and deliver a type of personalized cell therapy called CAR-T in Colombia. Second, it will test the safety of this specific CAR-T therapy in a small group of adults with advanced blood cancers that …
Matched conditions: MANTLE CELL LYMPHOMA (MCL)
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC